Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 14;17(6):e86030.
doi: 10.7759/cureus.86030. eCollection 2025 Jun.

Association of Dyslipidemia With Dermatological Manifestations in Patients With Type 2 Diabetes Mellitus

Affiliations

Association of Dyslipidemia With Dermatological Manifestations in Patients With Type 2 Diabetes Mellitus

Syeda Shahmoona Tirmizi et al. Cureus. .

Abstract

Objectives Type 2 diabetes mellitus (T2DM) is frequently related with various cutaneous manifestations, which may be influenced by comorbid conditions such as dyslipidemia. Hence, this study compared the demographic to match clinical and dermatological profiles of T2DM patients with and without dyslipidemia. Methodology This cross-sectional study was conducted at a secondary care hospital using a non-probability convenient sampling technique over six months. A total of 280 T2DM patients aged 40-65 years were included in this study. Patients were distributed into two equal groups: Group A (with dyslipidemia) and Group B (without dyslipidemia). Data on demographics, clinical history, lifestyle factors, treatment regimens, and dermatological findings were collected using structured questionnaires, physical examinations, and laboratory tests. A Chi-square test and a Mann-Whitney test were applied to examine the association of dermatological symptoms in T2DM. A p-value < 0.05 was reflected as statistically significant. Results The study findings showed that a significant gender disparity was observed: all patients in Group A were male subjects at 140 (100%), while Group B were predominantly female subjects at 88.6% (p<0.001). A larger proportion of Group A had diabetes for more than five years, 47 (33.6%) compared to Group B at 14 (10.0%), (p<0.001), and more frequent use of insulin and oral hypoglycemic agents (p=0.001). Xerosis with fissured skin was significantly more common in Group B at 109(77.9%), (p<0.001). The presence of bullae was also significantly greater in Group B at 54(38.6%) as compared to Group A at 25 (17.9%) (p<0.001). Although acanthosis nigricans showed no significant difference, it was slightly more prevalent in Group B. Conclusion This study concluded that the dermatological manifestations were common among T2DM patients, with notable differences based on dyslipidemia status. Patients without dyslipidemia showed a higher prevalence of xerosis, ichthyosis, callosities, and bullae, whereas paresthesias were more frequently observed in those with dyslipidemia.

Keywords: dermatological manifestations; dyslipidemia; symptoms; type 2 diabetes mellitus; xerosis.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Ethical Review Board, Sindh Government Hospital, Karachi issued approval SGH/(2.A/Landhi)1754. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

References

    1. Cutaneous manifestations associated with diabetes mellitus-a retrospective study. Vâță D, Stanciu DE, Temelie-Olinici D, Porumb-Andrese E, Tarcău BM, Grecu VB, Gheucă-Solovăstru L. Diseases. 2023;11 - PMC - PubMed
    1. Relationship between skin diseases and extracutaneous complications of diabetes mellitus: clinical analysis of 750 patients. Demirseren DD, Emre S, Akoglu G, Arpacı D, Arman A, Metin A, Cakır B. Am J Clin Dermatol. 2014;15:65–70. - PubMed
    1. Dyslipidemia in type 2 diabetes mellitus. Mooradian AD. Nat Clin Pract Endocrinol Metab. 2009;5:150–159. - PubMed
    1. Plasma lipidomic profiling and risk of type 2 diabetes in the PREDIMED trial. Razquin C, Toledo E, Clish CB, et al. Diabetes Care. 2018;41:2617–2624. - PMC - PubMed
    1. Lipidomic profiles in diabetes and dementia. Huynh K, Martins RN, Meikle PJ. J Alzheimers Dis. 2017;59:433–444. - PubMed

LinkOut - more resources